H1N1 vaccine for prevention of pandemic influenza

Medical Letter on Drugs and Therapeutics

Volumn 51, Issue 1322, 2009, Pages 77-78

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE;

DRUG EFFICACY; DRUG FORMULATION; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; PANDEMIC; SHORT SURVEY; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 70350214822     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605.
2. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58:521.
3. K Hancock et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: epub. September 10.
4. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morbid Mortal Wkly Rep 2009; 58 (RR-10):1.
5. DJ Jamieson et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451.
6. ME Greenberg et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine - Preliminary report. N Engl J Med 2009; 361: epub. September 10.
7. Seasonal trivalent influenza vaccine for 2009-2010. Med Lett Drugs Ther 2009; 51:73.